Font Size: a A A
Keyword [Recombinant human Granulocyte-colony Stimulating Factor]
Result: 41 - 60 | Page: 3 of 4
41. The Clinical Study Of Pegylated Recombinant Human Granulocyte Colony-stimulating Factor On Neutropenia In The Treatment Of Breast Cancer Patients With Chemotherapy
42. Clinical Analysis Of 11 Cases With Congenital Neutropenia
43. Preliminary Study On Recombinant Human Granulocyte Colony-stimulating Factor And Glucagon Like Peptide-1 Improve Ischemic Injury Of Acute Myocardial Infarction Model Rats
44. Clinical Research On The Effect Of Combined Stimulating Endometrium Hyperplasia On Repeated Implantation Failure Patients After Down Reglulation In Frozen Embryo Cycles
45. Clinical Analysis Of Recombinant Human Granulocyte Colony Stimulating Factor In The Treatment Of Breast Cancer After Chemotherapy
46. Clinical Pharmacokinetic Studies Of Pegylated Recombinant Human Granulocyte Colony Stimulating Factor
47. RhG-CSF Ameliorates Neuronal Apoptosis Via The MTOR/p70S6K Signaling Pathway In Neonatal Hypoxia-ischemia In Rats
48. Effect Of PEGylated Recombinant Human Granulocyte Colony-stimulating Factor On Prevention Of Neutropenia After Chemotherapy For Small Cell Lung Cancer
49. The Clinical Observation Of Yiqi Yangxue Recipe Combined With Recombinant Human Granulocyte Colony Stimulating Factor In The Treatment Of ?-? Degree Bone Marrow Suppression After Chemotherapy For Intestinal Cancer
50. Rational Evaluation Of The Utilization Of Recombinant Human Granulocyte Colony Stimulating Factor In Patients With Gynecological Malignant Tumor In A Hospital
51. Relationship Between Angiopoietin 2 And CD105 And Infarct Size In Rats With Acute Myocardial Infarction After RhG-CSF Intervention
52. Evaluation Of Efficacy And Medical Economics For Recombinant Human Granulocyte Colony-stimulating Factor In Therapy Of Induction For Acute Myeloid Leukemia In Childhood
53. Clinical Observaton Of Zaizhangshengxue Mixture In The Treatment Of Bone Marrow Suppression After Chemotherapy
54. The Effect Of Recombinant Human Granulocyte-colony Stimulating Factor On The Improvement Of Motor Function In Neonatal Hypoxic-ischemic Rats
55. Clinical Value Of Primary Prevention Of 3/4 Degree Neutropenia With PEGylated Recombinant Human Granulocyte Colony-stimulating Factor In Platinum-containing Dual-drug Chemotherapy For Elderly Patients With Advanced Lung Cancer
56. The Effects Of Pegylated Recombinant Human Granulocyte Colony-stimulating Factor On Small Cell Lung Cancer Immune Status
57. Analysis Of Agranulocytosis Time And Influencing Factors In Patients With Hematological Malignancies Treated With RhIL-11 Combined RhG-CSF After Chemotherapy
58. The Effect Of Pegylated Recombinant Human Granulocyte Colony Stimulating Factor For Primary Prevention Of Neutropenia After Chemotherapy In Ovarian Cancer
59. Pharmacokinetics And Safety Of Pegylated Recombinant Human Granulocyte Colony-Stimulating Factor In Children With Acute Leukemia
60. Retrospective Study Of Etoposide Combined With Pegylated Recombinant Human Granulocyte Colony-stimulating Factor For Mobilization Of Autologous Peripheral Blood Hematopoietic Stem Cells In Lymphoma Patients
  <<First  <Prev  Next>  Last>>  Jump to